| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/17/2008 | US20080014227 Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 01/17/2008 | US20080014195 Antagonists Of Myelin-Associated Glycoprotein And Their Use In The Treatment And/Or Prevention Of Neurological Diseases |
| 01/17/2008 | US20080014194 Using alpha-synuclein specific monoclonal antibody to diagnose, prevent and treat parkinson's disease |
| 01/17/2008 | US20080014193 Modulation of excitable tissue function by peripherally administered erythropoietin |
| 01/17/2008 | US20080014191 Treatment of Protein Misfolding |
| 01/17/2008 | US20080014189 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/17/2008 | US20080014178 Method for Stimulating Mammalian Cells and Mammalian Cell |
| 01/17/2008 | DE102006032427A1 Use of composition comprising e.g. clozapine, quetiapine, olanzapine, benzyl- and/or phenylethyl alcohol, ethanol, ethereal oil, sweetener, and polyethylene glycol, for preparing an orally administering solution to treat schizophrenia |
| 01/17/2008 | DE102006032426A1 Use of a composition comprising e.g. clozapine and quetiapine; benzyl- and/or phenylethyl alcohol; propylene glycol; ethereal oil; and polyethylene glycol, for preparing an orally administering solution to treat schizophrenia |
| 01/17/2008 | DE102006031813A1 Basische Acetophenone als Hemmstoffe von NO-Synthasen Basic acetophenones as inhibitors of NO synthases |
| 01/17/2008 | CA2658232A1 Use of flumazenil in the manufacture of a medicament for the treatment of depressive disorders |
| 01/17/2008 | CA2658097A1 Pentadienamide derivatives |
| 01/17/2008 | CA2657592A1 Adhesive patch containing fentanyl or a pharmaceutically acceptable salt thereof |
| 01/17/2008 | CA2657552A1 Substituted diazepan orexin receptor antagonists |
| 01/17/2008 | CA2657541A1 Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate |
| 01/17/2008 | CA2657535A1 Process for preparing diaminophenothiazinium compounds |
| 01/17/2008 | CA2657117A1 Crystals of benzoxadiazole derivative |
| 01/17/2008 | CA2657027A1 Use of trifluoromethyl substituted benzamides in the treatment of neurological disorders |
| 01/17/2008 | CA2656767A1 Polymorphic form of fluoro-7-(2,2,2-trifluoroethoxy) phenoxathiin-10,10-dioxide |
| 01/16/2008 | EP1878804A1 Perkinson disease-related gene grk5 and use thereof |
| 01/16/2008 | EP1878793A1 Novel protein and preventive/remedy for neurodegenerative disease such as polyglutamine disease using the same |
| 01/16/2008 | EP1878748A2 Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 costimulatory antigens |
| 01/16/2008 | EP1878743A2 Urotensin-II agonists and antagonists |
| 01/16/2008 | EP1878734A1 Novel lactam compound |
| 01/16/2008 | EP1878732A1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR |
| 01/16/2008 | EP1878727A1 2-aminoquinazoline derivatives |
| 01/16/2008 | EP1878725A2 Pyrimidine derivatives and their use as CB2 modulators |
| 01/16/2008 | EP1878723A1 N-[(1,5-diphenyl-1H-pyrazol-3-yl)methyl]sulfonamide derivatives antagonists of the CB1 cannabinoids receptors |
| 01/16/2008 | EP1878446A2 Formulation comprising buprenorphine |
| 01/16/2008 | EP1878444A1 Composition containing antidementia agent |
| 01/16/2008 | EP1878443A1 Therapeutic agent for neuropathic pain |
| 01/16/2008 | EP1878435A1 Composition for inducing sleep containing vegetable essential oil component as the active component, transdermal absorption type sleep inducing agent containing the composition and method of producing the same |
| 01/16/2008 | EP1877442A2 Antibodies directed against amyloid-beta peptide and methods using same |
| 01/16/2008 | EP1877422A1 Green tea polyphenol alpha secretase enhancers and methods of use |
| 01/16/2008 | EP1877399A1 Triazole derivatives as vasopressin antagonists |
| 01/16/2008 | EP1877391A1 Pro-drugs of n-thiazol-2yl-benzamide derivatives |
| 01/16/2008 | EP1877378A2 Oxindole compounds and their uses as therapeutic agents |
| 01/16/2008 | EP1877373A2 Biphenylazetidinone cholesterol absorption inhibitors |
| 01/16/2008 | EP1877367A1 Acetylene derivatives |
| 01/16/2008 | EP1877366A1 Hydroxamic acid dervicatives as inhibitors of hdac enzymatic activity |
| 01/16/2008 | EP1877365A1 Acetylene derivatives |
| 01/16/2008 | EP1877075A2 Antibodies to myostatin |
| 01/16/2008 | EP1877070A2 Dosage of oligonucleotides |
| 01/16/2008 | EP1877057A1 Use of pyrazolyl-pyrimidine derivatives in the treatment of pain |
| 01/16/2008 | EP1877052A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 01/16/2008 | EP1877044A2 N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions associated with oxidative stress |
| 01/16/2008 | EP1876900A2 Phosphoinositide modulation for the treatment of alzheimer's disease |
| 01/16/2008 | EP1773315B1 Arylacetic acids and related compounds for treatment of alzheimer's disease |
| 01/16/2008 | EP1713778B1 Benzazepine derivatives as histamine h3 antagonists |
| 01/16/2008 | EP1694673B1 Thiazole derivates |
| 01/16/2008 | EP1644320B1 Indane derivates as muscarinic receptor agonists |
| 01/16/2008 | EP1601659B1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands |
| 01/16/2008 | EP1599231A4 Treatment of pain through expression of opioid receptors |
| 01/16/2008 | EP1562918B1 Substituted benzoxazinones and uses thereof |
| 01/16/2008 | EP1501809B1 Triazole derivatives as tachykinin receptor antagonists |
| 01/16/2008 | EP1492793B1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives |
| 01/16/2008 | EP1458684B1 Therapeutic heterocycles as bradykinin b2 receptor antagonists |
| 01/16/2008 | EP1451154B1 Inhibitors of cytosolic phospholipase a2 |
| 01/16/2008 | EP1392306B1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 01/16/2008 | EP1340748B1 Quinazoline derivatives and drugs |
| 01/16/2008 | EP1278532B1 Plant extract of the olea europaea species as no-synthase inhibitor and uses |
| 01/16/2008 | EP1268835B1 Retinoic acid receptor beta-2 and gene therapy vectors for the treatment of neurological disorders |
| 01/16/2008 | EP1261694B1 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 01/16/2008 | EP1204626B1 Ether compounds, compositions, and uses thereof |
| 01/16/2008 | EP1173480B1 Stereoselective antifibrillogenic peptides |
| 01/16/2008 | EP1085848B1 Inhibitors of transcription factor nf-kappa b |
| 01/16/2008 | CN101107254A Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders |
| 01/16/2008 | CN101107239A N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid CB1 receptor antagonists |
| 01/16/2008 | CN101107238A Asymmetric synthesis of dihydrobenzofuran derivatives |
| 01/16/2008 | CN101107237A Asymmetric synthesis of substituted dihydrobenzofurans |
| 01/16/2008 | CN101107236A Cyclohexylamides as dopamine D3, D2 and 5HT1A antagonists |
| 01/16/2008 | CN101107228A Process for producing (Z)-1-phenyl-1-(N,N-diethylaminocarbonyl)-2-phthalimidomethylcyclopropane |
| 01/16/2008 | CN101106996A Use of oxycodone for treating visceral pain |
| 01/16/2008 | CN101104845A Use of protocatechuic acid in accelerating nerve stem cell multiplication in vitro and inducement differentiation |
| 01/16/2008 | CN101104616A Dehydrosilibinin diester derivatives, preparation method and use thereof |
| 01/16/2008 | CN101104612A Flavonol beta-secretase inhibitor in ginkgo leaf standard extract, extracting method and use thereof |
| 01/16/2008 | CN101104602A N-[(1,5-diphenyl-1H-pyrazol-3-yl)methyl]sulfamide derivative and its preparation and use |
| 01/16/2008 | CN101104063A Traditional Chinese medicine composition for treating apoplexy and hemiplegia |
| 01/16/2008 | CN101104058A Medicine for treating multi-inflammatory toothache and its preparation thereof |
| 01/16/2008 | CN101104041A Use of huoxiangzhengqi preparation in preparing sobering-up medicine |
| 01/16/2008 | CN101104033A Traditional Chinese medicinal preparation for treating Parkinson's disease and preparing process thereof |
| 01/16/2008 | CN101104029A Medicinal compositions |
| 01/16/2008 | CN101104022A Decoction medicine for treating molars in sleeping for child and preparation method |
| 01/16/2008 | CN101104016A Oral solid preparation of corydalis and its new use |
| 01/16/2008 | CN101103975A Phenytoin sodium powder injection and preparation method thereof |
| 01/16/2008 | CN101103969A Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 01/16/2008 | CN101103962A Vinpocetine oral self-micro-emulsification medicine-releasing system and preparation method thereof |
| 01/16/2008 | CN100361690C Medication for treating hypochondria and preparation method |
| 01/16/2008 | CN100361665C Compositions and methods for treatment of mitochondrial diseases |
| 01/15/2008 | US7319160 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 01/15/2008 | US7319138 Comprises transcription factor referred to as dragon protein (DRG) for treating and diagnosing nervous system, skin, muscle, bone and eye disorders |
| 01/15/2008 | US7319110 1H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activity |
| 01/15/2008 | US7319107 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 01/15/2008 | US7319106 such as (cis)-6-(3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane; for controlling synaptic transmission, neurotransmitter release |
| 01/15/2008 | US7319101 catechol-O-methyltransferase (COMT) inhibitors such as N-{3-[5-(6-Amino-purin-9-yl)-3,4-dihydroxy-tetrahydro-furan-2-yl]-allyl}-2,3-dihydroxy-benzamide used for the treatment of schizophrenia, Parkinson's disease and as antidepressants or cognition activators |
| 01/15/2008 | US7319100 1-(1H-Pyrazin-2-on-3-yl)tetrahydroquinolines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); treating anxiety and depression |
| 01/15/2008 | US7319099 Benzoyl-piperazine derivatives |
| 01/15/2008 | US7319094 Increased and sustained in vivo gene expression using a nucleic acid, histone and amphipathic compound composition |
| 01/15/2008 | US7319092 Methods of suppressing microglial activation |
| 01/15/2008 | CA2419934C Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |